8-OH-DPAT radioligand tritiated at the 1,2,3 position on the propyl-2,3-ring. 8-OH-DPAT is a serotonin receptor agonist specific for the 5-HT1A and 5-HT7 receptors.
For research use only. Not for use in diagnostic procedures.
Feature | Specification |
---|---|
Concentration | 1 mCi/ml |
Label Position | Specifically Labeled |
Molecular Weight | 247.4 |
Receptor | 5-Hydroxytryptamine |
8-OH-DPAT radioligand tritiated at the 1,2,3 position on the propyl-2,3-ring. 8-OH-DPAT is a serotonin receptor agonist specific for the 5-HT1A and 5-HT7 receptors.
250 µCi quantities of 8-Hydroxy-DPAT, [Propyl-2,3-ring-1,2,3-3H]-, are available for research. 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) is a highly selective full agonist of the 5-HT1A receptor that also stimulates the 5-HT7 receptor and has been shown to label 5-hydroxytryptamine (5-HT) reuptake sites. These receptors are part of a group of serotonin G-protein coupled receptors (GPCRs) found in the central and peripheral nervous systems, and modulate the release of neurotransmitters and hormones. 5-HT receptors are the pharmacological target of many antidepressants, antipsychotic, anti-migraine, and other pharmaceutical drugs.
We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.
Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.
References for NET929:
Concentration |
1 mCi/ml
|
---|---|
Molecular Weight |
247.4
|
Application |
Drug Discovery & Development
|
---|---|
Brand |
NEN Radiochemicals
|
Buffer/Solvent |
Ethanol
|
Detection Modality |
Radiometric
|
Label Position |
Specifically Labeled
|
Packaging |
NENSure vial
|
Radioisotope |
3H
|
Receptor |
5-Hydroxytryptamine
|
Shipping Conditions |
Shipped in Dry Ice
|
Special Ordering Information |
This is a radioactive product - shipping address must have a license to receive radioactive materials.
|
Storage Conditions |
-80°C
|
Therapeutic Area |
CNS & Neurologic
|
Unit Size |
250 µCi
|
Are you looking for resources, click on the resource type to explore further.
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.